Mesoblast Ltd Files 6-K Report
Ticker: MEOBF · Form: 6-K · Filed: Nov 17, 2025 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Nov 17, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
MESO files 6-K, standard reporting update.
AI Summary
On November 17, 2025, Mesoblast Limited filed a new release announcement with the Australian Securities Exchange. This filing is a Form 6-K report for the month of November 2025, indicating the company's ongoing reporting obligations. Mesoblast Limited is incorporated in Australia and its CEO is Silviu Itescu.
Why It Matters
This filing serves as an update for investors regarding Mesoblast Limited's regulatory and corporate activities. It confirms the company is meeting its reporting requirements with the SEC.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- November 17, 2025 (date) — Filing date
- Australian Securities Exchange (company) — Exchange where announcement was filed
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K filing is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of November 2025.
When was this announcement filed with the Australian Securities Exchange?
Mesoblast Limited filed a new release announcement with the Australian Securities Exchange on November 17, 2025.
Who is the Chief Executive Officer of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
Where is Mesoblast Limited incorporated?
Mesoblast Limited is incorporated in Australia.
Does Mesoblast Limited file annual reports under Form 20-F or Form 40-F?
Mesoblast Limited indicates it files annual reports under Form 20-F.
Filing Stats: 212 words · 1 min read · ~1 pages · Grade level 17.3 · Accepted 2025-11-17 11:10:22
Filing Documents
- form6-kxpressreleasecoverf.htm (6-K) — 15KB
- exhibit991cfo.htm (EX-99.1) — 9KB
- exhibit991cfo001.jpg (GRAPHIC) — 291KB
- exhibit991cfo002.jpg (GRAPHIC) — 258KB
- 0001345099-25-000097.txt ( ) — 781KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Paul Hughes Paul Hughes Company Secretary Dated November 17, 2025 INDEX TO EXHIBITS Item 99.1 Press release of Mesoblast Ltd, dated November 17, 2025.